Detalhe da pesquisa
1.
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
N Engl J Med
; 390(4): 301-313, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38084760
2.
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma.
Blood
; 137(22): 3027-3036, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33739404
3.
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
Hematol Oncol
; 40(4): 704-715, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608183
4.
Carfilzomib plus dexamethasone in patients with relapsed and refractory multiple myeloma: A retro-prospective observational study.
Eur J Haematol
; 109(4): 373-380, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35749094
5.
A multidisciplinary case report of multiple myeloma with renal and cardiac involvement: a look beyond amyloidosis.
BMC Nephrol
; 23(1): 370, 2022 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36397026
6.
A real-world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma.
Hematol Oncol
; 39(1): 41-50, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33085797
7.
Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study.
Medicina (Kaunas)
; 57(9)2021 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34577823
8.
Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients.
Eur J Haematol
; 104(2): 138-144, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31762088
9.
Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities?
Br J Haematol
; 193(4): e27-e31, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33840100
10.
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials.
Haematologica
; 106(1): 291-294, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107338
11.
Lenalidomide: A double-edged sword for concomitant multiple myeloma and post-essential thrombocythemia myelofibrosis.
Am J Hematol
; 96(6): 749-754, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33719069
12.
A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment.
Blood
; 120(6): 1197-201, 2012 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22740446
13.
Pregnancy complications predict thrombotic events in young women with essential thrombocythemia.
Am J Hematol
; 89(3): 306-9, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24265194
14.
Anti-BCMA CAR-T cell-based therapies and bispecific antibodies in the immunotherapy era: are we ready for this?
Expert Rev Hematol
; : 1-16, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38770902
15.
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.
Blood
; 117(22): 5857-9, 2011 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-21490340
16.
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis.
Blood
; 118(8): 2069-76, 2011 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21725052
17.
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network.
Front Oncol
; 13: 1162990, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37182182
18.
Thrombosis in primary myelofibrosis: incidence and risk factors.
Blood
; 115(4): 778-82, 2010 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-19965680
19.
Hydroxyurea in essential thrombocythemia: rate and clinical relevance of responses by European LeukemiaNet criteria.
Blood
; 116(7): 1051-5, 2010 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-20479281
20.
Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia.
Am J Hematol
; 87(2): 203-4, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22237692